Overcoming Immune Checkpoint Inhibitor Resistance with Potent, Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides
- Journal:
- Journal of the American Chemical Society
- Published:
- DOI:
- 10.1021/jacs.5c06142
- Affiliations:
- 1
- Authors:
- 12
| Institutions | Authors | Share |
|---|---|---|
| Lassogen, Inc., United States of America (USA) | 1.00 |